A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer (Q37225701)
Jump to navigation
Jump to search
scientific article published on 12 May 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer |
scientific article published on 12 May 2009 |
Statements
1 reference
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer (English)
1 reference
E Vasile
1 reference
G Masi
1 reference
L Fornaro
1 reference
S Cupini
1 reference
F Loupakis
1 reference
S Bursi
1 reference
I Petrini
1 reference
S Di Donato
1 reference
I M Brunetti
1 reference
S Ricci
1 reference
A Antonuzzo
1 reference
S Chiara
1 reference
D Amoroso
1 reference
M Andreuccetti
1 reference
A Falcone
1 reference
12 May 2009
1 reference
1 reference
1720-1724
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference